The China Congress of Cell Biology Industry and Biopharmaceutical Innovation Cooperation Conference (CBIC) will cover major topics such as antibody drugs, stem cells and regenerative medicine, immunotherapy, cell drugs, 3D cell culture, cell multi-omics, organoids, exosomes, target screening, pharmaceutical innovation, new vaccines, gene therapy, oncolytic viruses, etc. The conference will focus on the latest progress in biotechnology, clinical applications, industrialization process, investment and financing opportunities, industry standardization, and new regulatory trends.

Biopharmaceutical industry is one of the key strategic emerging industries that China focuses on developing. Currently, China is the second largest pharmaceutical market in the world, undergoing an important phase of strategic transformation from "generic drugs" to "innovative drugs". Precision medicine is driving a revolution in drug development, gene technology and cell engineering are bringing revolutionary changes to disease treatment, medical devices are moving towards intelligence and standardization, providing new diagnostic and therapeutic methods. Emerging biopharmaceutical service formats such as contract research organizations (CRO), contract manufacturing organizations (CMO), third-party testing, health management, etc., are continuously emerging and growing, leading to rapid growth in the biopharmaceutical industry.

In recent years, national and local governments have successively introduced a series of policies to promote the construction of the bioeconomy. Among them, the Bohai Rim region led by Beijing, Tianjin, Hebei, and Shandong, the Yangtze River Delta centered on Shanghai with Jiangsu and Zhejiang as its wings, and the Pearl River Delta with Guangzhou and Shenzhen as its leaders, have shown obvious industrial agglomeration effects and development advantages in the field of biopharmaceuticals.

The China Congress of Cell Biology Industry and Biopharmaceutical Innovation Cooperation Conference (CBIC) invites experts and advanced professionals from academia, innovative pharmaceutical companies, research institutions, hospitals, biotechnology enterprises, health management, medical aesthetics, venture capital, private equity investment institutions, industrial parks, industry associations, government regulatory agencies, etc., to gather together to discuss the current situation and future prospects of the industry, sharing new development opportunities in the industry.

The China Congress of Cell Biology Industry and Biopharmaceutical Innovation Cooperation Conference (CBIC) will also host related theme exhibitions concurrently, showcasing the industry's latest products, technologies, and services. The conference integrates national biopharmaceutical resources, providing participants with a one-stop platform for "academic exchange", "channel对接连接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接对接

Antibody drugs, stem cells and regenerative medicine, immunotherapy, cell drugs, 3D cell culture, cell multi-omics, organoids, exosomes, target screening, pharmaceutical innovation, new vaccines, gene therapy, oncolytic viruses, etc. (本文内容版权归属聚展所有，未经同意，禁止转发)